Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1
Open Access
- 16 August 2018
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (8) , 2427
Abstract
Crosstalk of a tumor with its microenvironment is a critical factor contributing to cancer development. This study investigates the soluble factors released by tumor-associated dendritic cells (TADCs) responsible for increasing cancer stem cell (CSC) properties, cell mobility, and epithelial-to-mesenchymal transition (EMT). Dendritic cells (DCs) of colon cancer patients were collected for phenotype and CXCL1 expression by flow cytometry and Luminex assays. The transcriptome of CXCL1-treated cancer cells was established by next generation sequencing. Inflammatory chemokine CXCL1, present in large amounts in DCs isolated from colon cancer patients, and SW620-conditioned TADCs, enhance CSC characteristics in cancer, supported by enhanced anchorage-independent growth, CD133 expression and aldehyde dehydrogenase activity. Additionally, CXCL1 increases the metastatic ability of a cancer by enhancing cell migration, matrix metalloproteinase-7 expression and EMT. The enhanced CXCL1 expression in DCs is also noted in mice transplanted with colon cancer cells. Transcriptome analysis of CXCL1-treated SW620 cells indicates that CXCL1 increases potential oncogene expression in colon cancer, including PTHLH, TYRP1, FOXO1, TCF4 and ZNF880. Concurrently, CXCL1 displays a specific microRNA (miR) upregulated by the prototypical colon cancer onco-miR miR-105. Analysis of publicly available data reveals CXCL1-driven oncogenes and miR-105 have a negative prognostic impact on the outcome of colon cancer. This study indicates a new mechanism by which the colon cancer milieu exploits DC plasticity to support cancer progression.Keywords
Funding Information
- Ministry of Science and Technology (MOST 104-2314-B-037-053-MY4, MOST 104-2320-B-037-014-MY3)
- Kaohsiung Medical University Hospital Research Foundation (KMUHS10601)
- Kaohsiung Medical University Research Foundation (105KMUOR05)
- KMU-KMUH Co-Project of Key Research (KMU-DK 107009)
- Ministry of Health and Welfare (MOHW106-TDU-B-212-144007)
This publication has 49 references indexed in Scilit:
- Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1Journal of Cellular Physiology, 2014
- Dendritic cell defects in the colorectal cancerHuman Vaccines & Immunotherapeutics, 2014
- Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLHNature Cell Biology, 2014
- Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote MetastasisCancer Cell, 2014
- Dendritic Cells: Arbiters of Immunity and Immunological ToleranceCold Spring Harbor Perspectives in Biology, 2012
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cellsEndocrine-Related Cancer, 2012
- PROGmiR: a tool for identifying prognostic miRNA biomarkers in multiple cancers using publicly available dataJournal of Clinical Bioinformatics, 2012
- The expression and role of CXC chemokines in colorectal cancerCytokine & Growth Factor Reviews, 2011
- The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissueBritish Journal of Cancer, 2011